Alector (ALEC) Total Non-Current Liabilities (2018 - 2026)

Alector (ALEC) posted quarterly Total Non-Current Liabilities of $227.8 million for Q1 2026, down 27.07% year-over-year from $312.3 million in Q1 2025, and down 12.68% quarter-over-quarter from $260.9 million in Q4 2025.

Alector (ALEC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Total Non-Current Liabilities for 9 consecutive years, with $227.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 27.07% year-over-year to $227.8 million; the TTM figure through Mar 2026 stood at $227.8 million (down 27.07% YoY), while the FY2025 annual figure was $260.9 million, down 23.34% from the prior year.
  • Total Non-Current Liabilities declined to $227.8 million in Q1 2026 per ALEC's latest filing, from $260.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $686.8 million in Q1 2022 and bottomed at $227.8 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $440.4 million across 5 years, with a median of $455.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 223.37% — and 2025, when it tumbled 32.25%.
  • Alector's Total Non-Current Liabilities stood at $572.4 million in 2022, then declined by 15.05% to $486.3 million in 2023, then sank by 30.03% to $340.3 million in 2024, then decreased by 23.34% to $260.9 million in 2025, then decreased by 12.68% to $227.8 million in 2026.
  • Business Quant data shows ALEC's Total Non-Current Liabilities at $227.8 million in Q1 2026, $260.9 million in Q4 2025, and $276.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Alector 218.85 Mn 46.05 Mn - 210.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 210.80 Mn
Mar 31, 2026 227.76 Mn
Dec 31, 2025 260.85 Mn
Sep 30, 2025 276.13 Mn
Jun 30, 2025 283.80 Mn
Mar 31, 2025 312.30 Mn
Dec 31, 2024 340.27 Mn
Sep 30, 2024 395.86 Mn
Jun 30, 2024 418.93 Mn
Mar 31, 2024 455.21 Mn
Dec 31, 2023 486.30 Mn
Sep 30, 2023 508.94 Mn
Jun 30, 2023 511.53 Mn
Mar 31, 2023 564.43 Mn
Dec 31, 2022 572.45 Mn
Sep 30, 2022 583.70 Mn
Jun 30, 2022 600.92 Mn
Mar 31, 2022 686.76 Mn
Dec 31, 2021 513.78 Mn
Sep 30, 2021 518.18 Mn